nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—ABCB1—Topotecan—cervical cancer	0.389	0.625	CbGbCtD
Fluvoxamine—CYP3A4—Topotecan—cervical cancer	0.233	0.375	CbGbCtD
Fluvoxamine—Bullous eruption—Topotecan—cervical cancer	0.0189	0.065	CcSEcCtD
Fluvoxamine—Pelvic pain—Topotecan—cervical cancer	0.0123	0.0422	CcSEcCtD
Fluvoxamine—Intestinal obstruction—Topotecan—cervical cancer	0.0109	0.0377	CcSEcCtD
Fluvoxamine—Neuralgia—Topotecan—cervical cancer	0.0107	0.037	CcSEcCtD
Fluvoxamine—Interstitial lung disease—Topotecan—cervical cancer	0.0105	0.0363	CcSEcCtD
Fluvoxamine—Dysmenorrhoea—Topotecan—cervical cancer	0.0082	0.0283	CcSEcCtD
Fluvoxamine—Bone pain—Topotecan—cervical cancer	0.00778	0.0268	CcSEcCtD
Fluvoxamine—Colitis—Topotecan—cervical cancer	0.00716	0.0247	CcSEcCtD
Fluvoxamine—Neuropathy—Topotecan—cervical cancer	0.007	0.0241	CcSEcCtD
Fluvoxamine—Rash maculo-papular—Topotecan—cervical cancer	0.00678	0.0234	CcSEcCtD
Fluvoxamine—Neoplasm—Topotecan—cervical cancer	0.00674	0.0232	CcSEcCtD
Fluvoxamine—Ear pain—Topotecan—cervical cancer	0.00634	0.0219	CcSEcCtD
Fluvoxamine—Dermatitis bullous—Topotecan—cervical cancer	0.00566	0.0195	CcSEcCtD
Fluvoxamine—Lethargy—Topotecan—cervical cancer	0.00552	0.019	CcSEcCtD
Fluvoxamine—Cardiac arrest—Topotecan—cervical cancer	0.00515	0.0177	CcSEcCtD
Fluvoxamine—Weight increased—Topotecan—cervical cancer	0.00426	0.0147	CcSEcCtD
Fluvoxamine—Pneumonia—Topotecan—cervical cancer	0.0042	0.0145	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Topotecan—cervical cancer	0.00409	0.0141	CcSEcCtD
Fluvoxamine—Stomatitis—Topotecan—cervical cancer	0.00407	0.014	CcSEcCtD
Fluvoxamine—Sweating—Topotecan—cervical cancer	0.004	0.0138	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Topotecan—cervical cancer	0.00395	0.0136	CcSEcCtD
Fluvoxamine—Epistaxis—Topotecan—cervical cancer	0.00393	0.0136	CcSEcCtD
Fluvoxamine—Haemoglobin—Topotecan—cervical cancer	0.00376	0.013	CcSEcCtD
Fluvoxamine—SIGMAR1—uterine cervix—cervical cancer	0.00375	0.0425	CbGeAlD
Fluvoxamine—Rhinitis—Topotecan—cervical cancer	0.00375	0.0129	CcSEcCtD
Fluvoxamine—Haemorrhage—Topotecan—cervical cancer	0.00374	0.0129	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Topotecan—cervical cancer	0.00373	0.0128	CcSEcCtD
Fluvoxamine—Pharyngitis—Topotecan—cervical cancer	0.00372	0.0128	CcSEcCtD
Fluvoxamine—SIGMAR1—decidua—cervical cancer	0.00358	0.0405	CbGeAlD
Fluvoxamine—Angiopathy—Topotecan—cervical cancer	0.0034	0.0117	CcSEcCtD
Fluvoxamine—SIGMAR1—endometrium—cervical cancer	0.0034	0.0384	CbGeAlD
Fluvoxamine—Chills—Topotecan—cervical cancer	0.00336	0.0116	CcSEcCtD
Fluvoxamine—Alopecia—Topotecan—cervical cancer	0.00331	0.0114	CcSEcCtD
Fluvoxamine—SIGMAR1—mammalian vulva—cervical cancer	0.00328	0.0372	CbGeAlD
Fluvoxamine—Malnutrition—Topotecan—cervical cancer	0.00326	0.0112	CcSEcCtD
Fluvoxamine—Back pain—Topotecan—cervical cancer	0.00315	0.0109	CcSEcCtD
Fluvoxamine—Muscle spasms—Topotecan—cervical cancer	0.00313	0.0108	CcSEcCtD
Fluvoxamine—SIGMAR1—uterus—cervical cancer	0.00313	0.0354	CbGeAlD
Fluvoxamine—Ill-defined disorder—Topotecan—cervical cancer	0.00302	0.0104	CcSEcCtD
Fluvoxamine—Anaemia—Topotecan—cervical cancer	0.00301	0.0104	CcSEcCtD
Fluvoxamine—Angioedema—Topotecan—cervical cancer	0.00298	0.0103	CcSEcCtD
Fluvoxamine—Malaise—Topotecan—cervical cancer	0.00294	0.0101	CcSEcCtD
Fluvoxamine—Leukopenia—Topotecan—cervical cancer	0.00292	0.0101	CcSEcCtD
Fluvoxamine—Cough—Topotecan—cervical cancer	0.00284	0.0098	CcSEcCtD
Fluvoxamine—SLC6A4—female reproductive system—cervical cancer	0.00283	0.0321	CbGeAlD
Fluvoxamine—Chest pain—Topotecan—cervical cancer	0.00278	0.00956	CcSEcCtD
Fluvoxamine—Myalgia—Topotecan—cervical cancer	0.00278	0.00956	CcSEcCtD
Fluvoxamine—Arthralgia—Topotecan—cervical cancer	0.00278	0.00956	CcSEcCtD
Fluvoxamine—Discomfort—Topotecan—cervical cancer	0.00274	0.00945	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Topotecan—cervical cancer	0.00266	0.00917	CcSEcCtD
Fluvoxamine—Infection—Topotecan—cervical cancer	0.00264	0.00911	CcSEcCtD
Fluvoxamine—Nervous system disorder—Topotecan—cervical cancer	0.00261	0.00899	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Topotecan—cervical cancer	0.0026	0.00898	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Topotecan—cervical cancer	0.00257	0.00886	CcSEcCtD
Fluvoxamine—SIGMAR1—female gonad—cervical cancer	0.00256	0.029	CbGeAlD
Fluvoxamine—CYP1A1—epithelium—cervical cancer	0.00255	0.0288	CbGeAlD
Fluvoxamine—SIGMAR1—vagina—cervical cancer	0.00254	0.0288	CbGeAlD
Fluvoxamine—Anorexia—Topotecan—cervical cancer	0.00254	0.00874	CcSEcCtD
Fluvoxamine—CYP1A1—uterine cervix—cervical cancer	0.00252	0.0286	CbGeAlD
Fluvoxamine—CYP3A5—uterine cervix—cervical cancer	0.00247	0.0279	CbGeAlD
Fluvoxamine—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00242	0.00835	CcSEcCtD
Fluvoxamine—CYP1A2—renal system—cervical cancer	0.00239	0.0271	CbGeAlD
Fluvoxamine—Paraesthesia—Topotecan—cervical cancer	0.00239	0.00823	CcSEcCtD
Fluvoxamine—Dyspnoea—Topotecan—cervical cancer	0.00237	0.00817	CcSEcCtD
Fluvoxamine—CYP1A1—renal system—cervical cancer	0.00236	0.0267	CbGeAlD
Fluvoxamine—Dyspepsia—Topotecan—cervical cancer	0.00234	0.00807	CcSEcCtD
Fluvoxamine—Decreased appetite—Topotecan—cervical cancer	0.00231	0.00797	CcSEcCtD
Fluvoxamine—CYP3A5—renal system—cervical cancer	0.00231	0.0261	CbGeAlD
Fluvoxamine—Gastrointestinal disorder—Topotecan—cervical cancer	0.0023	0.00792	CcSEcCtD
Fluvoxamine—CYP2B6—renal system—cervical cancer	0.00229	0.026	CbGeAlD
Fluvoxamine—Fatigue—Topotecan—cervical cancer	0.00229	0.00791	CcSEcCtD
Fluvoxamine—Pain—Topotecan—cervical cancer	0.00228	0.00784	CcSEcCtD
Fluvoxamine—Constipation—Topotecan—cervical cancer	0.00228	0.00784	CcSEcCtD
Fluvoxamine—CYP1A1—mammalian vulva—cervical cancer	0.00221	0.025	CbGeAlD
Fluvoxamine—Feeling abnormal—Topotecan—cervical cancer	0.00219	0.00756	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Topotecan—cervical cancer	0.00218	0.0075	CcSEcCtD
Fluvoxamine—CYP2E1—renal system—cervical cancer	0.00215	0.0244	CbGeAlD
Fluvoxamine—CYP2C19—vagina—cervical cancer	0.00212	0.024	CbGeAlD
Fluvoxamine—Urticaria—Topotecan—cervical cancer	0.00211	0.00728	CcSEcCtD
Fluvoxamine—CYP1A1—uterus—cervical cancer	0.0021	0.0238	CbGeAlD
Fluvoxamine—Abdominal pain—Topotecan—cervical cancer	0.0021	0.00725	CcSEcCtD
Fluvoxamine—Body temperature increased—Topotecan—cervical cancer	0.0021	0.00725	CcSEcCtD
Fluvoxamine—Hypersensitivity—Topotecan—cervical cancer	0.00196	0.00676	CcSEcCtD
Fluvoxamine—Asthenia—Topotecan—cervical cancer	0.00191	0.00658	CcSEcCtD
Fluvoxamine—CYP1A1—female reproductive system—cervical cancer	0.00189	0.0214	CbGeAlD
Fluvoxamine—Pruritus—Topotecan—cervical cancer	0.00188	0.00649	CcSEcCtD
Fluvoxamine—CYP2B6—female reproductive system—cervical cancer	0.00184	0.0208	CbGeAlD
Fluvoxamine—Diarrhoea—Topotecan—cervical cancer	0.00182	0.00627	CcSEcCtD
Fluvoxamine—CYP2C9—female reproductive system—cervical cancer	0.00182	0.0206	CbGeAlD
Fluvoxamine—Dizziness—Topotecan—cervical cancer	0.00176	0.00606	CcSEcCtD
Fluvoxamine—CYP3A4—renal system—cervical cancer	0.00173	0.0196	CbGeAlD
Fluvoxamine—CYP2E1—female reproductive system—cervical cancer	0.00172	0.0195	CbGeAlD
Fluvoxamine—CYP1A1—female gonad—cervical cancer	0.00172	0.0195	CbGeAlD
Fluvoxamine—CYP1A1—vagina—cervical cancer	0.00171	0.0194	CbGeAlD
Fluvoxamine—CYP2D6—renal system—cervical cancer	0.0017	0.0193	CbGeAlD
Fluvoxamine—Vomiting—Topotecan—cervical cancer	0.00169	0.00583	CcSEcCtD
Fluvoxamine—CYP3A5—female gonad—cervical cancer	0.00168	0.019	CbGeAlD
Fluvoxamine—Rash—Topotecan—cervical cancer	0.00168	0.00578	CcSEcCtD
Fluvoxamine—Dermatitis—Topotecan—cervical cancer	0.00168	0.00578	CcSEcCtD
Fluvoxamine—CYP3A5—vagina—cervical cancer	0.00167	0.0189	CbGeAlD
Fluvoxamine—Headache—Topotecan—cervical cancer	0.00167	0.00574	CcSEcCtD
Fluvoxamine—CYP2B6—vagina—cervical cancer	0.00166	0.0188	CbGeAlD
Fluvoxamine—SIGMAR1—lymph node—cervical cancer	0.00165	0.0186	CbGeAlD
Fluvoxamine—Nausea—Topotecan—cervical cancer	0.00158	0.00545	CcSEcCtD
Fluvoxamine—CYP3A4—female reproductive system—cervical cancer	0.00139	0.0157	CbGeAlD
Fluvoxamine—CYP2D6—female reproductive system—cervical cancer	0.00137	0.0155	CbGeAlD
Fluvoxamine—ABCB1—epithelium—cervical cancer	0.00132	0.015	CbGeAlD
Fluvoxamine—ABCB1—uterine cervix—cervical cancer	0.00131	0.0148	CbGeAlD
Fluvoxamine—ABCB1—decidua—cervical cancer	0.00125	0.0141	CbGeAlD
Fluvoxamine—CYP2D6—female gonad—cervical cancer	0.00124	0.0141	CbGeAlD
Fluvoxamine—ABCB1—renal system—cervical cancer	0.00123	0.0139	CbGeAlD
Fluvoxamine—ABCB1—endometrium—cervical cancer	0.00119	0.0134	CbGeAlD
Fluvoxamine—ABCB1—mammalian vulva—cervical cancer	0.00115	0.013	CbGeAlD
Fluvoxamine—CYP1A1—lymph node—cervical cancer	0.00111	0.0125	CbGeAlD
Fluvoxamine—ABCB1—uterus—cervical cancer	0.00109	0.0124	CbGeAlD
Fluvoxamine—ABCB1—female reproductive system—cervical cancer	0.000982	0.0111	CbGeAlD
Fluvoxamine—ABCB1—female gonad—cervical cancer	0.000894	0.0101	CbGeAlD
Fluvoxamine—ABCB1—vagina—cervical cancer	0.000888	0.0101	CbGeAlD
Fluvoxamine—ABCB1—lymph node—cervical cancer	0.000575	0.0065	CbGeAlD
